BCKDK accelerates the progression of diabetic kidney disease by regulating leucine-mediated metabolic remodelling in renal tubular cells
Caifeng Shi(Second Affiliated Hospital of Nanjing Medical University), Yang Zhou(Second Affiliated Hospital of Nanjing Medical University), Xueting Zhu(Second Affiliated Hospital of Nanjing Medical University), Lulu Wang(Second Affiliated Hospital of Nanjing Medical University), Qingqing Ke(Second Affiliated Hospital of Nanjing Medical University), Yu Xiao(Soochow University), Ke Zen(Nanjing Drum Tower Hospital), Chunsun Dai(Nanjing Medical University), Dandan Liu(Second Affiliated Hospital of Nanjing Medical University), Xiaomei Wu(Second Affiliated Hospital of Nanjing Medical University), Xin Yu(Second Affiliated Hospital of Nanjing Medical University), Xingyue Wang(Second Affiliated Hospital of Nanjing Medical University), Yuting Sheng(Second Affiliated Hospital of Nanjing Medical University), Aiqin He(Second Affiliated Hospital of Nanjing Medical University), Xinjia Shen(Second Affiliated Hospital of Nanjing Medical University), Yemeng Wan(Second Affiliated Hospital of Nanjing Medical University), Lei Jiang(Wuhan City Chinese Medicine Hospital), Songyan Qin(Second Affiliated Hospital of Nanjing Medical University), Rui Shen(Chinese University of Hong Kong, Shenzhen)
Cited by 4
Related Papers
Exogenous plant MIR168a specifically targets mammalian LDLRAP1: evidence of cross-kingdom regulation by microRNA
|Cell Research|2011|1.2k
Pyruvate kinase type M2 promotes tumour cell exosome release via phosphorylating synaptosome-associated protein 23
|Nature Communications|2017|310
The miR-200 family regulates TGF-β1-induced renal tubular epithelial to mesenchymal transition through Smad pathway by targeting ZEB1 and ZEB2 expression
|American Journal of Physiology-Renal Physiology|2011|258
Inhibiting aerobic glycolysis suppresses renal interstitial fibroblast activation and renal fibrosis
|American Journal of Physiology-Renal Physiology|2017|238